Authors: Martha Powell, Future Science Group
Neisseria gonorrhoea continues to show high levels of azithromycin resistance, according to the European Gonococcal Antimicrobial Surveillance Programme (Euro-GASP). However, overall the rates of resistance for cefixime, ceftriaxone and azithromycin have remained relatively stable when compared to recent years.
Gonorrhea is the second most commonly notified sexually transmitted infection in countries of the EU and the European Economic Region, with more than 75,000 reported cases in 2016. With limited alternatives to the current combination therapy, controlling drug-resistance is crucial.